MENU
+Compare
NONOF
Stock ticker: OTC
AS OF
Apr 3 closing price
Price
$67.14
Change
-$1.08 (-1.58%)
Capitalization
299.64B

NONOF Novo-Nordisk A/S Forecast, Technical & Fundamental Analysis

With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world... Show more

NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NONOF with price predictions
Apr 03, 2025

NONOF's Indicator enters downward trend

The Aroon Indicator for NONOF entered a downward trend on April 03, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 105 similar instances where the Aroon Indicator formed such a pattern. In of the 105 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NONOF as a result. In of 118 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NONOF turned negative on March 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at .

NONOF moved below its 50-day moving average on March 10, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NONOF crossed bearishly below the 50-day moving average on March 13, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NONOF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NONOF advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .

NONOF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (14.368) is normal, around the industry mean (13.581). P/E Ratio (20.509) is within average values for comparable stocks, (64.662). Projected Growth (PEG Ratio) (1.041) is also within normal values, averaging (1.879). Dividend Yield (0.025) settles around the average of (0.025) among similar stocks. P/S Ratio (7.133) is also within normal values, averaging (248.206).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NONOF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
NONOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published Dividends

NONOF paid dividends on August 18, 2021

Novo-Nordisk A/S NONOF Stock Dividends
А dividend of $7.00 per share was paid with a record date of August 18, 2021, and an ex-dividend date of August 16, 2021. Read more...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BKPSX51.14N/A
N/A
ProFunds Banks UltraSector Svc
JBAFX28.38N/A
N/A
JHancock Balanced R4
FGIQX15.38N/A
N/A
Macquarie Growth and Income R6
UIEMX20.91N/A
N/A
Victory Emerging Markets Institutional
TLATX10.66N/A
N/A
Transamerica Large Core ESG I3

NONOF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NONOF has been closely correlated with NVO. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NONOF jumps, then NVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NONOF
1D Price
Change %
NONOF100%
-1.59%
NVO - NONOF
70%
Closely correlated
-1.67%
LABFF - NONOF
23%
Poorly correlated
N/A
IMRN - NONOF
22%
Poorly correlated
+2.86%
QSI - NONOF
21%
Poorly correlated
-5.69%
VRTX - NONOF
21%
Poorly correlated
+0.11%
More

Groups containing NONOF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NONOF
1D Price
Change %
NONOF100%
-1.59%
Pharmaceuticals
category (304 stocks)
12%
Poorly correlated
-1.28%